2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
Merck Announces First Patient Dosed in Phase III Study of Or... (2024-09-05)
¡®Ã³¿ë2¡¯ ÀüÈ¿¼º, ¡®¿©°í»ý ±Í½Å¡¯ ¸Â¾Æ? ¸ö »ç¸®Áö ¾Ê´Â ÃÔ¿µ... (2015-09-21)
À½¾Ç¸í»ó¡¤Æ÷·¹½ºÆ® Èú¸µ¿ä°¡ (2014-11-07)
Organon Launches ¡°Her Plan is Her Power,¡± a New Global Ini... (2023-03-08)
Á¦·ÎÀ̵å, Áß±¹ LK±×·ì°ú MOU ü°á (2023-10-07)
µðÁö¸ó IP ½ÅÀÛ °ÔÀÓ ¡®µðÁö¸ó ½´ÆÛ·³ºí¡¯ Á¦ÀÛ (2021-06-13)
±í°í ªÀº ¹ÝµµÃ¼ »çÀÌŬ ¸ÂÃç ¹æ¹ý·Ð ã¾Æ¾ß (2024-01-04)
NetApp Expands Intelligent Data Infrastructure Capabilities ... (2024-07-16)
¡®¼¼°èÀ¯»ê ¿©Çà±³½Ç¡¯ ¿Â¶óÀÎ ¹®È­´Ù¾ç¼º ¼ö¾÷ ÁøÇà (2023-11-30)
HID Wins Contract to Provide Finland with New Driver¡¯s Lice... (2023-11-30)
¿À¶Ñ±â, ºñº­¸Ô°í »Ñ·Á¸Ô´Â ¡®¸¶¶óÀ塯 ½ÅÁ¦Ç° 2Á¾ (2024-01-23)
±Á³× µà¸Õ, ¡®ÇØÇÇ ´º µàµàµ¥ÀÌ¡¯ ¿ÀÇ (2024-01-23)
ºê¶óº¸ÅØ NZXT F120/F140 RGB DUO ½Ã¸®Áî (2023-01-19)
¾Ë¸®¹Ù¹Ù±×·ì 1688´åÄÄ, ¿Âä³Î°ú Çѱ¹ µµ¸Å½ÃÀå °ø·« (2024-05-26)
°æÁÖ½Ã, ³óÃÌüÇè°ü±¤ °¥¼ö·Ï °¢±¤ (2015-06-06)
¡®¼öÆÛ ¼¿·´¡¯ ±âÀº¼¼, ÀÏ»ó ¹Ý¿µÇÑ ¸ÞÀÌÅ©¾÷ È­º¸ °ø°³ (2017-06-13)
¹ö°ÅÅ·, ¡®14000¿ø ÀÌ»ó ÁÖ¹® ½Ã ³Ê°ÙÅ· 6Á¶°¢ ¹«·á (2017-04-04)
'³Ñ¹ö½º' ±è¸í¼ö, Á¾¿µ¼Ò°¨... ¹è¿ì·Î¼­ ÁøÀϺ¸ (2023-08-04)
KB±¹¹ÎÀºÇà, ¡®¸ð¹ÙÀÏ ½ÅºÐÁõ ¹Î°£°³¹æ Âü¿©±â¾÷¡¯ ÃÖÁ¾ ¼±Á¤ (2024-06-14)
Sh¼öÇùÀºÇà, »õÃâ¹ü ±â³ä °í°´°¨»ç Á¤±â¿¹±Ý ÆÇ¸Å (2016-11-02)
Å©¸°ÅØ Ã»¼ÒÂ÷ T350, T500e ½ÅÀåºñ ·ÐĪ (2018-03-10)
KT¿Í LGÀ¯Ç÷¯½º, SKT-CJHVÀμöÇÕº´¿¡ ¹Ý¹ß (2015-12-29)
NETSCOUT Identified Nearly 7.9 Million DDoS Attacks in 1H202... (2023-09-27)
Á¦2ÆÇ±³Å×Å©³ë¹ë¸® ÆÇ±³Ã¢¾÷Á¸, ÀÔÁÖ±â¾÷ ¸ðÁý (2023-11-01)
¿ì¸®ÀºÇà ¡®³õÄ£º¸Çè±Ýã±â¡¯ ¼­ºñ½º Ãâ½Ã (2023-12-06)
       [ÀÌÀü][1]....[863][864][865][866][867][868][869][870][871]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..